University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Philip Leboit, M.D.

Dermatopathologist

Clinics

Melanoma Center
1600 Divisadero St.,
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Philip Leboit

Education

Albany Medical College 1979

Residencies

Mt Sinai School of Medicine, Pathology 1982
UCSF Medical Center, Pathology 1982
UCSF Medical Center, Laboratory Medicine 1985

Fellowships

New York University, Dermatopathology 1982
New York Hospital/Cornell, Dermatopathology 1983

Selected Research and Publications

  1. Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, McCalmont TH, Bastian BC, LeBoit PE. Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol. 2014 Aug; 38(8):1088-95.
  2. Hall BJ, LeBoit PE. Suprabasal Spread of Melanocytes in Dysplastic Nevi and Melanoma In Situ: Ki-67-labeling Rate of Junctional Melanocytes and Suprabasal Cells May Be a Helpful Clue to the Diagnosis. Am J Surg Pathol. 2014 Aug; 38(8):1111-7.
  3. Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, Fullen DR, Guitart J, LeBoit PE, Mihm MC, Prieto VG, Rabkin MS, Scolyer RA, Xu X, Yun SJ, Obregon R, Yazdan P, Cooper C, Weitner BB, Rademaker A, Barnhill RL. Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up. Am J Surg Pathol. 2014 Jul; 38(7):934-40.
  4. North JP, Garrido MC, Kolaitis NA, Leboit PE, McCalmont TH, Bastian BC. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. Am J Surg Pathol. 2014 Jun; 38(6):824-31.
  5. Chua SL, Amerson EH, Leslie KS, McCalmont TH, Leboit PE, Martin JN, Bangsberg D, Maurer TA. Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era. Br J Dermatol. 2014 Apr; 170(4):832-9.
  6. Yang SH, Leboit PE. Angiomatous kaposi sarcoma: a variant that mimics hemangiomas. Am J Dermatopathol. 2014 Mar; 36(3):229-37.
  7. Naujokas A, Charli-Joseph Y, Ruben BS, Yeh I, Leboit PE, McCalmont TH, Pincus LB. SOX-10 expression in cutaneous myoepitheliomas and mixed tumors. J Cutan Pathol. 2014 Apr; 41(4):353-63.
  8. Charli-Joseph Y, Chong K, Ai WZ, Leboit PE, Pincus LB. Paraneoplastic acanthosis nigricans paralleling disease course in a patient with mycosis fungoides. Eur J Dermatol. 2013 Dec 1; 23(6):907-8.
  9. Kollipara R, Cooley LD, Horii KA, Hetherington ML, Leboit PE, Singh V, Zwick DL. Spitzoid melanoma in a child with li-fraumeni syndrome. Pediatr Dev Pathol. 2014 Jan-Feb; 17(1):64-9.
  10. Berliner JG, Haemel A, Leboit PE, Pincus LB. The sarcoidal variant of annular elastolytic granuloma. J Cutan Pathol. 2013 Nov; 40(11):918-20.
  11. Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov; 26(6):845-51.
  12. Wood BA, LeBoit PE. An 'inflammatory' variant of solar purpura: a simulant of leukocytoclastic vasculitis and neutrophilic dermatoses. Pathology. 2013 Aug; 45(5):484-8.
  13. Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, Prieto VG, Leboit PE, Barnhill RL, Cooper C, Yazdan P, Guitart J, Liu P, Pestova E, Busam K. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013 May; 37(5):676-84.
  14. LeBoit PE. Simulators of cutaneous lymphoma: where should our efforts go? Am J Clin Pathol. 2013 Apr; 139(4):414-7.
  15. Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V, Chong K, Peng L, Dimon MT, Phillips T, Daud AI, McCalmont TH, LeBoit PE, Ortiz-Urda S. Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo. Proc Natl Acad Sci U S A. 2013 Mar 5; 110(10):4015-20.
  16. North JP, Yeh I, McCalmont TH, LeBoit PE. Melanoma ex blue nevus: two cases resembling large plaque-type blue nevus with subcutaneous cellular nodules. J Cutan Pathol. 2012 Dec; 39(12):1094-9.
  17. Sun BK, Saggini A, Sarin KY, Kim J, Benjamin L, LeBoit PE, Khavari PA. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol. 2013 Mar; 133(3):824-7.
  18. Yeh I, McCalmont TH, LeBoit PE. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma. Br J Dermatol. 2012 Nov; 167(5):1106-10.
  19. Hope TA, Leboit PE, High WA, Fu Y, Brasch RC. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. Magn Reson Imaging. 2013 Jan; 31(1):139-44.
  20. Dalton SR, Chandler WM, Abuzeid M, Hossler EW, Ferringer T, Elston DM, LeBoit PE. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages. Am J Dermatopathol. 2012 Aug; 34(6):586-91.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.